Bellerophon Therapeutics News

Bellerophon Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Mar 7 00:34

Bellerophon Therapeutics | 8-K: Current report

Mar 5 06:55

Bellerophon Therapeutics | DEFA14A: Others

Feb 13 04:50

Bellerophon Therapeutics | DEFA14A: Others

Feb 13 01:40

Bellerophon Therapeutics | 8-K: Current report

Jan 30 22:32

Bellerophon Therapeutics | 8-K: Current report

Jan 22 13:00

Bellerophon Therapeutics | 8-K: Current report

Jan 10 13:00

Bellerophon Therapeutics | DEFA14A: Others

Jan 3 13:00

Bellerophon Therapeutics | 8-K: Current report

Dec 13, 2023 05:10

Bellerophon Therapeutics | 8-K: Current report

Nov 22, 2023 05:05

Bellerophon Therapeutics | DEF 14A: Definitive information statements

Nov 7, 2023 05:30

Bellerophon Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 27, 2023 22:50

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:59

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:58

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:58

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:57

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:56

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:56

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:55

Bellerophon Therapeutics | S-8 POS: S-8 POS

Oct 17, 2023 01:54